1. Home
  2. SRPT vs SOLV Comparison

SRPT vs SOLV Comparison

Compare SRPT & SOLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • SOLV
  • Stock Information
  • Founded
  • SRPT 1980
  • SOLV 2023
  • Country
  • SRPT United States
  • SOLV United States
  • Employees
  • SRPT N/A
  • SOLV N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • SOLV
  • Sector
  • SRPT Health Care
  • SOLV
  • Exchange
  • SRPT Nasdaq
  • SOLV NYSE
  • Market Cap
  • SRPT 12.2B
  • SOLV 12.6B
  • IPO Year
  • SRPT 1997
  • SOLV N/A
  • Fundamental
  • Price
  • SRPT $104.54
  • SOLV $67.52
  • Analyst Decision
  • SRPT Strong Buy
  • SOLV Hold
  • Analyst Count
  • SRPT 21
  • SOLV 9
  • Target Price
  • SRPT $182.00
  • SOLV $68.00
  • AVG Volume (30 Days)
  • SRPT 1.0M
  • SOLV 1.1M
  • Earning Date
  • SRPT 11-06-2024
  • SOLV 11-26-2024
  • Dividend Yield
  • SRPT N/A
  • SOLV N/A
  • EPS Growth
  • SRPT N/A
  • SOLV N/A
  • EPS
  • SRPT 1.22
  • SOLV 4.16
  • Revenue
  • SRPT $1,640,348,000.00
  • SOLV $8,215,000,000.00
  • Revenue This Year
  • SRPT $45.98
  • SOLV $2.17
  • Revenue Next Year
  • SRPT $78.13
  • SOLV $0.30
  • P/E Ratio
  • SRPT $85.70
  • SOLV $16.21
  • Revenue Growth
  • SRPT 48.45
  • SOLV 0.60
  • 52 Week Low
  • SRPT $78.67
  • SOLV $47.16
  • 52 Week High
  • SRPT $173.25
  • SOLV $77.17
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 23.65
  • SOLV N/A
  • Support Level
  • SRPT $116.32
  • SOLV N/A
  • Resistance Level
  • SRPT $122.63
  • SOLV N/A
  • Average True Range (ATR)
  • SRPT 4.97
  • SOLV 0.00
  • MACD
  • SRPT -2.19
  • SOLV 0.00
  • Stochastic Oscillator
  • SRPT 6.47
  • SOLV 0.00

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development.

About SOLV SOLVENTUM CORP

Solventum Corp is an independent healthcare company with a primary focus on addressing healthcare challenges. Its diverse product portfolio spans the healthcare industry, including medical solutions, oral care, health information systems, and separation and purification sciences.

Share on Social Networks: